Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$8.20 – $8.85
100% from low
Exchange
OTC Link
OS
P/S (TTM)
0.8
EV / FCF (TTM)
18.3
GRIFOLS SA B SHS NEW
No one on the platform currently holds GIFOF.
No tracked institution reports a position in GIFOF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-01 | $0.0925 | 2026-07-02 |
| 2025-08-12 | $0.1500 | 2025-08-13 |
| Execution date | Ratio |
|---|---|
| 2016-01-29 | 2-for-1 |
| 2012-12-11 | 21-for-20 |
No one on the platform has traded GIFOF yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 6.8% | 3.8% | 6.3% | — | — | — |
| Rev. Growth % | 4.3% | 7.1% | ||||
| Profit Margin % | 5.3% | 3.1% | 8.2% | |||
| Free Cash Flow Margin % | 10.4% | 3.2% | 6.1% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is +12.3% on the P/E track.
At today's price, your expected annual return is +17.6% on the P/E track.
At today's price, your expected annual return is +22.3% on the P/E track.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $7.7B | +2.5% | $0.83 | $0.82–$0.86 | 10.6× | 1 |
| 2027 | $8.2B | +6.1% | $1.08 | $1.06–$1.12 | 8.2× | 1 |
| 2028 | $8.6B | +5.7% | $1.42 | $1.39–$1.46 | 6.2× | 1 |
| 2029 | $9.2B | +6.6% | $1.61 | $1.58–$1.66 | 5.5× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-28 | $0.26 | $0.25 | -3.4% |
| 2026-05-07 | $0.16 | $0.17 | +8.0% |
| 2026-02-26 | $0.30 | $0.29 | -1.9% |
| 2025-11-04 | $0.24 | $0.21 | -13.8% |
| 2025-08-01 | $0.23 | $0.23 | -0.3% |
| 2025-05-12 | $0.15 | $0.13 | -13.7% |
| 2025-02-26 | $0.23 | $0.24 | +3.5% |
| 2024-11-07 | $0.22 |
| $0.25 |
| +14.9% |
| $7.0B |
| — |
| OPHLYOno Pharmaceutical Co., Ltd. | $4.91 | -1.80% | $6.9B | — |
| RCDTFRecordati S.p.A. | $58.00 | +0.00% | $11.9B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.